Curavit

Boston, United States

Curavit is a purpose-built to design and execute decentralized clinical trials.

$5.0M raised

Nov 2022

Series A

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Curavit raised?

Curavit has raised $5.0M in total funding. The most recent round was Series A. The last funding was announced in November 2022.

Who are Curavit's investors?

Curavit's investors include Osage Venture Partners, Royal Street Ventures, Narrow Gauge Ventures, Matt Wallach, Clark Golestani.

Where is Curavit headquartered?

Curavit is headquartered in Boston, United States.

What does Curavit do?

Curavit is a purpose-built to design and execute decentralized clinical trials.

What stage is Curavit at?

Curavit is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 14, 2022.

MLA

"Curavit — Funding & Investors." VCBacked, November 14, 2022, https://www.vcbacked.co/company/curavit. Accessed July 3, 2026.

APA

VCBacked. (2022). Curavit — Funding & Investors. Retrieved July 3, 2026, from https://www.vcbacked.co/company/curavit

Wikipedia (cite web)

{{cite web |title=Curavit — Funding & Investors |url=https://www.vcbacked.co/company/curavit |website=VCBacked |access-date=July 3, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 14, 2022.